Trial Profile

Cystic Fibrosis Treatment Adherence Cayston Proof-of-Concept Pilot Study

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 19 Sep 2016

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Aztreonam (Primary)
Indications Cystic fibrosis
Focus Proof of concept; Therapeutic Use
Acronyms MOMMI1

Most Recent Events

07 Sep 2016 Status changed from recruiting to completed.
05 Jan 2015 Status changed from not yet recruiting to recruiting, as reported by ClinicalTrials.gov.
05 Jan 2015 Treatment period has been changed from 56 days to 28 days, patient number decreased from 40 to 22 and date and time of dosing, dose amount by drug removed from treatment table.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com